Green John L.
Chief Financial Officer
Green John L. has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Dec 30, 2025.
On the most recent filing, Green John L. is listed as Chief Financial Officer at Cogent Biosciences, Inc. Inside the rolling window, Green John L. reported no open-market purchases and 1 open-market sale totaling $3.0M in COGT.
Companies traded
Other insiders at COGT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Green John L. made?
Green John L. has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Green John L. trade?
Green John L. has filed SEC Form 4 disclosures for 1 company, including COGT.
When was Green John L.'s most recent SEC Form 4 filing?
Green John L.'s most recent SEC Form 4 filing on Tracefour is dated Dec 30, 2025.
What is Green John L.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Green John L. is listed as Chief Financial Officer.
What is Green John L.'s total buy and sell value in the current window?
Inside the rolling retention window, Green John L. bought $0 and sold $3.0M based on SEC Form 4 filings.
What was Green John L.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 77,000 COGT shares on 2025-12-26, worth $3.0M, per SEC Form 4 filings.